glp-1 consultation Obesity Treatment: What Clinicians Must Know GLP-1 Maintenance: What Happens After

Everyone is incredibly nice and informative

10.1111/dom.13538 3 BuckleyS

The Role of the Microbiome in Drug Response

Semaglutide and Tirzepatide should not be used in combination with other GLP-1 receptor agonists or other products intended for weight loss, including prescription drugs, over-the-counter drugs, or herbal weight loss products

The NHS recommends starting with lifestyle interventions including dietary modification, increased physical activity, and behavioural support

Profile 3: Poorly Controlled or Unstable Psychiatric Illness Semaglutide and tirzepatide carry no specific psychiatric black box warning, but the FDA's Adverse Event Reporting System (FAERS) contains post-marketing reports of suicidal ideation associated with GLP-1 agents, prompting the FDA to open a signal evaluation in 2023 [7]